D-PENICILLAMINE-INDUCED MYASTHENIA-GRAVIS - DIAGNOSIS OBSCURED BY COEXISTING CHRONIC OBSTRUCTIVE PULMONARY-DISEASE

Citation
Hm. Adelman et al., D-PENICILLAMINE-INDUCED MYASTHENIA-GRAVIS - DIAGNOSIS OBSCURED BY COEXISTING CHRONIC OBSTRUCTIVE PULMONARY-DISEASE, The American journal of the medical sciences, 309(4), 1995, pp. 191-193
Citations number
19
Categorie Soggetti
Medicine, General & Internal
ISSN journal
00029629
Volume
309
Issue
4
Year of publication
1995
Pages
191 - 193
Database
ISI
SICI code
0002-9629(1995)309:4<191:DM-DOB>2.0.ZU;2-5
Abstract
D-penicillamine, a drug used to treat rheumatoid arthritis, Wilson's d isease, and cystinuria, can cause myasthenia gravis. Fortunately, the myasthenia typically resolves after discontinuation of the drug. The d iagnosis may be missed if weakness is blamed on a patient's underlying disease(s), in particular, rheumatoid arthritis. Reported here are th e cases of two patients with chronic obstructive lung disease who were taking D-penicillamine for rheumatoid arthritis, then experienced inc reasing respiratory failure. At first, their problem seemed to stem fr om chronic lung disease, but further evaluation revealed the cause of the hypoventilation to be D-penicillamine-induced myasthenia gravis.